The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortium.
Clicks: 236
ID: 43304
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
76.7
/100
229 views
186 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The NIH Roadmap Epigenomics Program was launched to deliver reference epigenomic data from human tissues and cells, develop tools and methods for analyzing the epigenome, discover novel epigenetic marks, develop methods to manipulate the epigenome, and determine epigenetic contributions to diverse human diseases. Here, we comment on the outcomes from this program: the scientific contributions made possible by a consortium approach and the challenges, benefits, and lessons learned from this group science effort.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (73 words).
Try re-searching for a better abstract.
| Reference Key |
satterlee2019thescience
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Satterlee, John S;Chadwick, Lisa H;Tyson, Frederick L;McAllister, Kim;Beaver, Jill;Birnbaum, Linda;Volkow, Nora D;Wilder, Elizabeth L;Anderson, James M;Roy, Ananda L; |
| Journal | Science advances |
| Year | 2019 |
| DOI |
10.1126/sciadv.aaw6507
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.